These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 7681711

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Felty's Syndrome.
    Pixley JS, Patchin GM.
    BioDrugs; 1997 May; 7(5):356-65. PubMed ID: 18031099
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 May; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.
    Bohlius J, Reiser M, Schwarzer G, Engert A.
    Br J Haematol; 2003 Aug; 122(3):413-23. PubMed ID: 12877668
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Felty's syndrome: effects of splenectomy upon granulocyte count and granulocyte-associated IgG.
    Blumfelder TM, Logue GL, Shimm DS.
    Ann Intern Med; 1981 May; 94(5):623-8. PubMed ID: 7235395
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B, Csernok E, Schatz H, Gross WL, Schnabel A.
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [Abstract] [Full Text] [Related]

  • 56. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P.
    AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI, Rivera F, Díaz-Puente MT, Lianes P, Colomer R, López-Brea M, López E, Paz-Ares L, Hitt R, García-Ribas I.
    J Natl Cancer Inst; 1995 Jun 07; 87(11):803-8. PubMed ID: 7540696
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.